Credit: Pixabay/CC0 Public Domain Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs. The design and preclinical evaluation of the CAR-T cells, led by Melita Irving and Greta...
Tag: <span>CAR-T cancer therapy</span>
Post
Landmark CAR-T cancer study published
How CAR-T cell therapy harnesses a patient’s immune system to fight cancer. Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient’s immune system to attack cancer cells. Patrick Stiff, MD, director of Loyola’s Cardinal Bernardin Cancer Center,...